Language Function in Patients With Brain Tumors
Completed
- Conditions
- Brain CancerCNS Cancer
- Interventions
- Other: fMRI Scan, pre- and post language evaluation
- Registration Number
- NCT00599703
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to use an imaging method called functional magnetic resonance imaging (fMRI) in patients who have a tumor near an area of the brain that is believed to control language. The fMRI is a new kind of imaging that uses a strong magnetic field to look at functioning brain tissue. This kind of imaging will be used to study the effect of the brain tumor on your speech.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7
Inclusion Criteria
- Patient in whom a tumor invades or is directly adjacent to the expected location of one of the language centers.
- At least 18 years of age
- English as first language
Read More
Exclusion Criteria
- Patients with high grade tumors
- History of significant psychiatric condition (e.g. schizophrenia, obsessive-compulsive disorder, significant dementia),
- History of the following neurological conditions: CVA, demyelinating conditions, cerebral palsy, Alzheimer's disease.
- History of significant claustrophobic reactions.
- Pregnancy
- Standard contraindications to MR examinations (e.g. implanted stimulator)
- Patients, who were treated prior to our first scan, will not be eligible to participate in this study
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 fMRI Scan, pre- and post language evaluation neurosurgical patients
- Primary Outcome Measures
Name Time Method To identify language organization prior to surgery in patients in whom a tumor invades or is directly adjacent to the expected location of one of the language centers. conclusion of study
- Secondary Outcome Measures
Name Time Method To assess language reorganization over time. conclusion of study
Trial Locations
- Locations (1)
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States